- Home
- OUT vs MANE Comparison
OUT vs MANE Comparison
Compare OUT & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUT | MANE |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.3B |
| IPO Year | 2013 | 2026 |
Fundamental Metrics
Financial Performance| Metric | OUT | MANE |
|---|---|---|
| Price | $30.13 | $130.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $38.00 | ★ $163.50 |
| AVG Volume (30 Days) | ★ 1.4M | 795.6K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,831,700,000.00 | N/A |
| Revenue This Year | $9.12 | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | $54.78 | ★ N/A |
| Revenue Growth | ★ 0.04 | N/A |
| 52 Week Low | $16.97 | $36.26 |
| 52 Week High | $34.96 | $136.72 |
Technical Indicators
Market Signals| Indicator | OUT | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 67.50 |
| Support Level | $29.48 | $92.62 |
| Resistance Level | $30.84 | N/A |
| Average True Range (ATR) | 0.59 | 8.26 |
| MACD | 0.31 | 1.15 |
| Stochastic Oscillator | 100.00 | 82.09 |
Price Performance
Historical ComparisonAbout OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The company has two reportable operating segments: Billboard and Transit. It derives maximum revenue from Billboard Segment. The company geographically operates in United States and Canada, of which United States derive maximum revenue.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.